Won-Keun Kim, Christian Hengstenberg, Michael Hilker, Sebastian Kerber, Ulrich Schäfer, Tanja Rudolph, Axel Linke, Norbert Franz, Thomas Kuntze, Holger M. Nef, Utz Kappert, Michael O. Zembala, Stefan Toggweiler, Thomas Walther, Helge Möllmann
- Objectives: The SAVI-TF (Symetis ACURATE neo Valve Implantation Using Transfemoral Access) registry was initiated to study the ACURATE neo transcatheter heart valve in a large patient population treated under real-world conditions.
Background: The self-expanding, supra-annular ACURATE neo prosthesis is a transcatheter heart valve that gained the Conformité Européene mark in 2014, but only limited clinical data are available so far.
Methods: This prospective, multicenter registry enrolled 1,000 patients at 25 European centers who were followed for 1 year post-procedure.
Results: Mean patient age was 81.1 ± 5.2 years; mean logistic European System for Cardiac Operative Risk Evaluation I score, European System for Cardiac Operative Risk Evaluation II score, and Society of Thoracic Surgeons score were 18.1 ± 12.5%, 6.6 ± 7.5%, and 6.0 ± 5.6%, respectively. At 1 year, 8.0% (95% confidence interval [CI]: 6.3% to 9.7%) of patients had died, 2.3% (95% CI: 1.3% to 3.2%) had disabling strokes, and 9.9% (95% CI: 8.1% to 11.8%) had permanent pacemaker implantations. Through 1 year, 5 reinterventions (0.5%; 95% CI: 0.1% to 1.0%) were performed: 3 valve-in-valve and 2 surgical aortic valve replacements. Mean effective orifice area was 1.84 ± 0.43 cm2, mean gradient was 7.3 ± 3.7 mm Hg, and greater than mild paravalvular leakage was observed in 3.6% of patients.
Conclusions: Transfemoral implantation of the ACURATE neo prosthesis resulted in favorable 1-year clinical and echocardiographic outcomes with very low mortality and new pacemaker rates.
MetadatenAuthor: | Won-Keun Kim, Christian Hengstenberg, Michael Hilker, Sebastian Kerber, Ulrich Schäfer, Tanja Rudolph, Axel Linke, Norbert Franz, Thomas Kuntze, Holger M. NefORCiDGND, Utz Kappert, Michael O. Zembala, Stefan Toggweiler, Thomas WaltherGND, Helge MöllmannORCiDGND |
---|
URN: | urn:nbn:de:hebis:30:3-471682 |
---|
DOI: | https://doi.org/10.1016/j.jcin.2018.03.023 |
---|
ISSN: | 1876-7605 |
---|
ISSN: | 1936-8798 |
---|
Pubmed Id: | https://pubmed.ncbi.nlm.nih.gov/30025731 |
---|
Parent Title (English): | JACC Cardiovascular interventions |
---|
Publisher: | Elsevier ; American College of Cardiology |
---|
Place of publication: | New York, NY |
---|
Contributor(s): | Beatrix Dörr |
---|
Document Type: | Article |
---|
Language: | English |
---|
Year of Completion: | 2018 |
---|
Date of first Publication: | 2018/07/16 |
---|
Publishing Institution: | Universitätsbibliothek Johann Christian Senckenberg |
---|
Release Date: | 2018/09/04 |
---|
Tag: | ACURATE neo; TAVR; aortic stenosis; transcatheter aortic valve replacement; transfemoral |
---|
Volume: | 11 |
---|
Issue: | 14 |
---|
Page Number: | 7 |
---|
First Page: | 1368 |
---|
Last Page: | 1374 |
---|
Note: | © 2018 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/) |
---|
HeBIS-PPN: | 437852199 |
---|
Institutes: | Medizin / Medizin |
---|
Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
---|
Sammlungen: | Universitätspublikationen |
---|
Licence (German): | Creative Commons - Namensnennung-Nicht kommerziell - Keine Bearbeitung 4.0 |
---|